Successfully Fast-Track Your LNPs from Concept to Market at the Largest Meeting Dedicated Purely to LNPs Worldwide
With Arbor Biotechnologies unveiling FDA approval of an IND filing for their LNP-mediated treatment for primary hyperoxaluria type 1, LNPs continue to be the hottest delivery vehicle across all payload types and completely dominate the non-viral delivery field, the promise of this delivery vehicle is truly ground-breaking!
Landing at The Westin Copley Place in Boston, the 4th LNP Formulation & Process Development Summit returns as the only industry summit dedicated to navigating LNP bottlenecks of designing novel ionizable lipids, achieving extrahepatic delivery, improving thermostability and accomplishing large scale manufacturing for advancing LNPS for a variety of applications towards the patients in need.
With a revamped track design, the 2025 meeting has 3 dedicated streams Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing to deep dive into an end-to-end strategy for revolutionizing the discovery and development of potent, safe and stable LNPs for targeted delivery of cell therapies, gene therapies, mRNA therapeutics and beyond!
Uniting 230+ LNP trailblazers from across the globe, this is your one-stop-shop for LNP specific networking, partnership opportunities and collaborative discussions to further fuel advancement of LNPs towards clinical development.
Companies Attending in April:
2025 Expert Speakers Include:
Room Block Now Available!
We are pleased to announce that for 4th LNP Formulation & Process Development Summit, We have a dedicated room block at the conference hotel, The Westin Copley Place Boston.
Book your reservations now to avoid disappointment! Deadline to book Monday, March 24.
What’s New in 2025?
In addition to the unrivalled scientific content in the form of presentations, roundtable discussion, panels and workshops, there will be a variety of extra experiences allowing for maximum ROI out of your time at the conference.
Refreshed Conference Streams
We’ve strengthened this year’s conference with industry experts to ensure it remains comprehensive and highlights the industry’s most relevant areas of interest. This year offers three parallel tracks – Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing - designed to optimize your LNP development
LNP 101 Day
Join the 101 Day to equip you and your team with the essential tools and fundamental principles for successful LNP development, showcasing the full potential of LNPs across various payloads and disease areas led by the likes of AstraZeneca, Takeda, Regeneron & more.
2-Track Workshop Day
With Eli Lilly & Co, AbbVie, Vertex Pharmaceuticals, Pfizer and more securing their place at the Pre-Conference Workshop Day, limited slots remain to deep dive into key challenges, including lipid library development, extrahepatic delivery, optimizing CMC of LNPs and overcoming IP bottlenecks, to accelerate novel and innovative LNPs towards the market.
Poster Session
Interested in hearing what your peers are up to, or even sharing research of your own? The poster session will unleash the latest innovations as part of the main conference program for no extra charge.
Deadline to submit a poster is April 4th
Networking Opportunities
Nothing embodies the LNP Formulation & Process Development Summit like our dedicated networking opportunities! The 2025 event will feature a drinks reception, speed networking sessions, awards evening, and more, bringing together over 230+ biopharma experts from the likes of Pfizer, Life Edit Therapeutics, CureVac and more committed to advancing LNPs.
The Inaugural LNP Awards
VOTING NOW OPEN
The inaugural LNP Awards will take place at the 2025 summit, honoring success, progress, and achievements within the LNP community. Join us as you and fellow industry members recognize and celebrate the best that the LNP sector has to offer.
What Previous Attendees of the LNP Series Had To Say:
This meeting is an excellent opportunity to connect with my counterparts in the biotech community and learn about the latest progress and challenges in advancing LNPs towards new medicinal products
Vice President, Head of Process Development, Sail Biomedicines
For professionals interested in deepening their understanding of Lipid Nanoparticles (LNPs) or seeking a comprehensive update in this field, I highly recommend attending this conference. This event will provide an invaluable overview of the current industry landscape and emerging trends in LNP technology
Scientist, Takeda Pharmaceuticals
Attending the 4th LNP Formulation & Process Development Summit provides significant value. It offers an excellent platform for engaging with experts and discussing the latest advancements in LNP technology.
Director, Non-Viral Delivery, Mammoth Biosciences
2025 Partners
Lead Partner
Expertise Partner
Program Partners
Other Events in the Series
